More News

  • ITAC Health Governance Committee Announces 2017 – 2018 Board of Directors

    June 9, 2017

    ITAC Health announces appointment of Susanne Flett, President of Healthtech Consultants, as Vice Chair and gives thanks to outgoing Board members

    Toronto (June 09, 2017) – ITAC Health Board approved the Board of Directors Slate for the 2017 to 2018 term at their recent Board meeting held on June 7, 2017 in Toronto, in conjunction with ... Read more

  • 2017 Canadian Health Informatics Award Winners announced at June 5 Gala

    June 9, 2017

    CHIA Gala Celebrates Canadian Excellence

    Toronto (June 08, 2017)  – The Canadian Health Informatics Awards (CHIA) Gala on June 5, 2017 honoured the digital health leaders, newcomers, and visionaries who are reimagining healthcare delivery in Canada today. Winners were honoured in the following categories:

    Steven Huesing Scholarship Award: Janessa Griffith, a PhD Student at ... Read more

  • VirtualArmour Confirms New Multi-Year Contract with Leading Healthcare Technology Firm

    June 8, 2017

    VANCOUVER, B.C., June 08, 2017 (GLOBE NEWSWIRE) — Premier Managed Services Provider, VirtualArmour International Inc. (the “Company”) (CSE:VAI), announced today a signed, multi-year Managed Services contract with one of the world’s leading healthcare technology providers.

    The contract will see VirtualArmour assume the ongoing responsibility for the ... Read more

  • Thousands of Canadians walking with JDRF to find a cure for type 1 diabetes

    June 8, 2017

    TORONTO, ON–(Marketwired – June 08, 2017) – On June 11 and other selected dates this month, over 40,000 Canadians across the country will rally together at the 2017 JDRF TELUS Walk to Cure Diabetes, to raise awareness and funds and help change the face of type 1 diabetes (T1D) forever. This year, JDRF aims to ... Read more

  • 3D Signatures Advances Hodgkin’s Lymphoma Test

    June 8, 2017

    TORONTO, June 08, 2017 (GLOBE NEWSWIRE) — 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”), is pleased to announce that the clinical trial component (the “Clinical Trial”) of its Hodgkin’s lymphoma (“HL”) test (“Telo-HL”) validation program is successfully underway. This process is referred to as Stage 3 of the ... Read more

  • 4C Medical’s Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

    June 8, 2017

    BROOKLYN PARK, Minn., June 8, 2017 /PRNewswire/ — 4C Medical Technologies, Inc., a developer of minimally invasive therapies for structural heart disease, today announced that its medical device therapy for mitral regurgitation (MR) will be featured in the Innovation Forum at the Transcatheter Valve Therapies (TVT) conference June 14-17, 2017 in Chicago, IL. The company is ... Read more

  • IntelGenx Announces Issuance of US Patent for Topical Oral Film Technology

    June 8, 2017

    SAINT LAURENT, QUEBEC–(Marketwired – June 8, 2017) – IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform, today announced that the ... Read more

  • Infoway Selects TELUS Health for PrescribeIT

    May 11, 2017

    May 11, 2017 (Toronto) – Canada Health Infoway (Infoway) is pleased to announce that it has selected TELUS Health as the successful bidder for the technical solution provider for PrescribeIT™, Canada’s e-prescribing service.

    “TELUS Health proposed an innovative approach that together with their advanced capabilities and capacity to deliver on our vision make them an ideal ... Read more